Lymphocyte phenotyping in systemic sclerosis: A flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid

Analytical and Quantitative Cytology and Histology

Volumn 19, Issue 3, 1997, Pages 264-270

  Domagała Kulawik, Joanna ^a   Hoser, Grazyna ^b   Kawalec, Maciej ^b   Doboszyńska, Anna ^a   Kawiak, Jerzy ^b   Droszcz, Wacław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Alveolitis, fibrosing; Bronchoalveolar lavage; Flow cytometry; Monoclonal antibodies; Progressive sclerosis, systemic

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR CELL; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

SCLERODERMA;

EID: 1842376873     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Agostini C, Chilosi M, Zambello R, Trentin L, Semenzato G: Pulmonary immune cells in health and disease: Lymphocytes. Eur Respir J 1993;6:1378-1401
2. Agostini C, Semenzato G: Immune responses in the lung: Basic principles. Lung (suppl) 1990;168:1001-1012
3. Ancochea J, Gonzalez A, Sanchez MJ, Aspa J, Lopez Botet M: Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest 1993;104:32-37
4. Benecic D, Betinic D, Cucevic I, Boranic M, Miculinic N: The role of T-lymphocyte subpopulation in bronchoalveolar lavage in pulmonary parenchymal disease. Sarcoidosis 1990;7:106-109
5. Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM: Lymphocyte recruitment to the lung. Am Rev Respir Dis 1990;142:238-257
6. Bienenstock J: Bronchus associated lymphoid tissue. In Immunology of the Lung and Upper Respiratory Tract. Edited by J Bienenstock. New York, McGraw-Hill, 1984, pp 96-118
7. Bruns M, Herrmann K, Uwe-Frithjof H: Immunologic parameters in systemic sclerosis. Int J Dermatol 1994;33:25-32
8. Dalhoff K, Bohnet S, Braun J, Kreft B, Wiessmann KJ: Intercellular adhesion molecule 1 (ICAM-1) in the pathogenesis of mononuclear cell alveolitis in pulmonary sarcoidosis. Thorax 1993;48:1140-1144
9. Dauber JH, Wagner M, Brunsvold S, Paradis IL. Ernst LA, Waggoner A: Flow cytometric analysis of lymphocyte phenotypes on bronchoalveolar lavage fluid: Comparison of a two-color technique with a standard immunoperoxidase assay. Am J Respir Cell Mol Biol 1992;7:531-524
10. Domagala-Kulawik J, Marsan C: Opracowanie popluczyn oskrzelowo-pecherzykowych w pracowni patomorfologii. Warszawa, Sanmedia, 1993
11. Frieri M, Angadi C, Paolano A, Oster SP, Blau SP, Yang S, Mele C, Hawrylko E: Altered T cell subpopulations and lymphocytes expressing natural killer cell phenotypes in patients with progressive systemic sclerosis. J Allergy Clin Immunol 1991;87:773-779
12. Frigieri L, Mormile F, Grilli N, Mancini G, Ciappi G, Pagliari G, Magaro M: Bilateral bronchoalveolar lavage in progressive systemic sclerosis: Interlobar variability, lymphocyte subpopulations, and functional correlations. Respiration 1991;58:132-140
13. Gudbjornsson B, Hallgren R, Nettelbladt O, Gustaffson R, Mattsson A, Geijerstam AF, Totterman TH: Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjogren's syndrome. Ann Rheum Dis 1994;53:574-579
14. Guidry GG, Beathage BA, Payne DK, Grafton WD: Pulmonary fibrosis as the initial manifestation of scleroderma. J Louisiana State Med Soc 1990;142:33-36
15. Gustafsson R, Totterman TH, Klareskog L, Hallgren R: Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990;49:40-45
16. Harrison NK, McAnulty RJ, Haslam PL, Black CM, Laurent GJ: Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis. Thorax 1990;45:606-610
17. Harrison NK, Myers AR, Corrin B, Soosay G, Dewar A, Black CM, Du Bois RM, Turner-Warwick M: Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706-713
18. Haslam PL: Evaluation of alveolitis by studies of lung biopsies. Lung (suppl) 1990;168:984-992
19. Klech H, Pohl W: Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989; 2:561-585
20. Kradin RL, Divertie MB, Colvin RB, Ramirez JCJ, Bhan AK: Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopatol 1986;40:224-235
21. Le Roy EC, Trojanowska M, Smith EA: The pathogenesis of scleroderma/systemic sclerosis, SSc. Clin Exp Rheumatol 1991;9:173-177
22. Lomeo RM, Cornelia RJ, Schabel SI, Silver RM: Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med 1989;87:525-527
23. McCarthy DS, Baragar FD, Dhingra S, Sigurdson M: The lungs in systemic sclerosis (scleroderma): A review and new information. Semin Arthritis Rheum 1988;17:271-283
24. Merchant RK, Swartz DA, Helmers RA: Bronchoalveolar lavage cellularity: The distribution in normal volunteers. Am Rev Respir Dis 1992;146:448-453
25. Miller KS, Smith EA, Kinsella M, Schabel SI, Silver RM: Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Am Rev Respir Dis 1990;141:301-306
26. Owens GR, Paradis IL, Gryzan S, Medsger TA: Role of inflammation in the lung disease of systemic sclerosis: Comparison with idiopathic pulmonary fibrosis. J Lab Clin Med 1986;107:253-260
27. Quantier PHH: Lung volumes and forced ventilatory flows: Report of the working party standardisation of lung function tests: European Community for Steel and Coal. Eur Respir J 1993;6s:5-40
28. Reynolds HY: Respiratory host defenses: Surface immunity. Immunology 1994;191:402-412
29. Rossi JP, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG: Evidence for chronic inflammation as a component of interstitial lung disease associated with progressive sclerosis. Am Rev Respir Dis 1985;131:612-617
30. Singer NG, Todd RF, Fox DA: Structures on the cell surface: Update from Fifth International Workshop on Leukocyte Differentiation Antigens. Arthritis Rheum 1994;37:1245-1248
31. Steen VD: Systemic sclerosis. In The Lung in Rheumatic Disease. Edited by WG Cannon. New York, Marcel-Decker, 1990, pp 279-302
32. Subcommittee for Scleroderma criteria, American Rheumatism Association, Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for classification of systemic sclerosis. Arthritis Rheum 1980;23:581-590
33. Turner Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: Response to corricosteroid treatment and its effect on survival. Thorax 1980;35:593-599
34. Wallaert B: Subclinical alveolitis in immunologie systemic disorders. Lung (suppl) 1990;168:974-983
35. Wallaert B, Bart F, Aerts C, Ouassi A, Tonnel AB, Voisin C: Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular disease. Thorax 1988;43: 24-30
36. Wallaert B, Harton PY, Grosbois JM, Tonnel AB, Devulder B, Voisin C: Subclinical pulmonary involvement in collagen-vascular disease assessed by bronchoalveolar lavage. Am Rev Respir Dis 1986;133:574-580
37. Wells AU, Hansell DM, Rubens MB, Cullinan P, Haslam PL, Black CM, Du Bois RM: Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150:462-468